American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

Clinician, Consumer Guides on Type 2 Diabetes, Autism Outline Therapy Options

Resources are Free for Physicians, Patients, Caregivers

By News Staff

The Effective Health Care Program of the Agency for Healthcare Research and Quality, or AHRQ, recently posted free summary guides for clinicians and consumers that discuss treatment options for adults with type 2 diabetes and children with autism spectrum disorders.

Type 2 Diabetes

Patient Care
Comparing Medications for Adults With Type 2 Diabetes is an update to AHRQ's 2007 review of oral medications for type 2 diabetes. The clinician guide now includes information about newer medications and two-drug combinations. The document, which is based on an AHRQ comparative effectiveness review (650-page PDF; About PDFs) of 166 clinical studies, is intended to help physicians discuss treatment options with patients and assist them in decision-making.

The guide does not cover nonmedical interventions, such as nutrition, physical activity or weight loss.

The "Clinical Bottom Line" section of the guide includes the following findings:
  • on average, many monotherapies reduce hemoglobin A1c, or HbA1c, levels by 1 percent;
  • on average, two-drug combination therapies reduce HbA1c by 1 percent more than monotherapies;
  • metformin was associated with less weight gain compared with other monotherapies or combination therapies; and
  • glucagon-like peptide-1 receptor agonists were associated with less weight gain than were second-generation sulfonylureas.

Story Highlights

  • The Agency for Healthcare Research and Quality has released two sets of summary guides aimed at clinicians and consumers that discuss the treatment of adults with type 2 diabetes and therapies for children with autism.
  • Both sets of guides are based on comparative effectiveness reviews of more than 150 clinical studies and cover the risks and benefits associated with various treatment options.
  • The resources are available online, and free print copies also are available from the agency.
This section of the guide also discusses potential side effects, such as the fact that thiazolidinediones are associated with a higher risk of congestive heart failure compared with sulfonylureas, and thiazolidinediones alone or in combination with other drugs are associated with an increased risk of fractures compared with other medications.

The related consumer guide reviews the risks, benefits and costs of 11 brand-name diabetes medications and their generic equivalents, as well as seven drug combinations.

Autism Therapy

Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders is based on a review (908-page PDF; About PDFs) of 159 clinical studies. The clinician guide examines therapies for children ages 2-12 years that focus on improving key deficits in social communication, addressing challenging behaviors, treating commonly associated difficulties, promoting functional independence and improving quality of life.

The potential causes of autism are not addressed in the guide.

The "Clinical Bottom Line" section of the guide includes the following findings:
  • Evidence indicates that aripiprazole and, to a lesser extent, risperidone reduce challenging and repetitive behaviors compared with placebo. Both drugs, however, are associated with significant weight gain, sedation and extrapyramidal effects.
  • Secretin does not improve language, cognition, behavior, communication, autism symptom severity or socialization.
  • Evidence is insufficient to understand the effectiveness, benefits or adverse events from any allied health or complementary and alternative medicine interventions, any educational interventions and most behavioral interventions.
The related consumer guide provides an overview of the types of programs and therapies available to children, available evidence about each program or therapy, and questions to ask when planning therapies and programs.

Free print copies of the guides may be requested by email or by calling the AHRQ Publications Clearinghouse at (800) 358-9295.


Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

Though Waning, H7N9 Still Poses Pandemic Potential

AUA Says No to Routine PSA Screening

AAFP Criticizes Appeal of Plan B One-Step Ruling

AAFP to Hospitals: Stop Early Elective Deliveries

AAFP, USPSTF Differ Somewhat on HIV Screening Guidance

Zoledronic Acid Confers Both Pros, Cons

ACP Issues Guidance on PSA Screening

Abbott Recalls FreeStyle InsuLinx Blood Glucose Meter

Discuss Drug Options With Women at Risk for Breast Cancer

Shingles Vaccine Effective, But Uptake Is Low

Evidence Lacking to Make Oral Cancer Screening Recommendation

Two External Guidelines Get Qualified AAFP Endorsement

USPSTF Recommends BRCA Testing for High-risk Women

Primary Care, Public Health Look for Ways to Integrate

Malfunction Prompts Glucose Meter Recall

Evidence Lacking on PAD Screening, Says USPSTF

Azithromycin Poses Arrhythmia Risk, Says FDA

Vets With PTSD Often Prescribed Inappropriate Meds

AIM-HI Offers Grants to Combat Childhood Obesity

USPSTF Says No to Low-dose Vitamin D, Calcium to Prevent Fractures

PCV13, HibMenCY Vaccine Changes Approved by ACIP

AAFP, Other Groups Release More Choosing Wisely Lists

National Office Champions Tobacco Cessation Project Successful

USPSTF Issues Draft Statement on Glaucoma Screening

Study Examines Overuse, Inappropriate Use of Health Services

Apply to Become an AAFP Vaccine Science Fellow

Study Looks to Reduce PSA Screening Risks

AAP Issues New Clinical Guidance on Type 2 Diabetes

CDC: Adult Vaccination Rates Still Too Low

Pertussis Outbreaks Declining, but Immunization Still Key

2013 Immunization Schedules Include Several Changes

FDA Warns of Liver Injury Risk With Samsca Use

FDA Approves First Recombinant Trivalent Influenza Vaccine

AAFP, USPSTF: Screen Women of Childbearing Age for Partner Violence

Breast Cancer Screening in Older Women Costly, Likely Ineffective

CDC Gives Flu Update, Urges Continued Vaccination

Aerobic Exercise Beats Resistance Training for Weight Control